Cargando…

New applications of the acridine orange fluorescence staining method: Screening for circulating tumor cells

The aim of the present study was to explore use of the acridine orange fluorescence (AO-F) staining method for screening of circulating tumor cells (CTCs) in renal cell carcinoma (RCC) patients. The AO-F positive staining rate of live and dead tumor cells was calculated. The positive staining rate i...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Min, Li, Ruizhe, Tang, Yang, Chang, Jiwu, Han, Rong, Zhang, Shumin, Jiang, Ning, Ma, Fuling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403171/
https://www.ncbi.nlm.nih.gov/pubmed/28454384
http://dx.doi.org/10.3892/ol.2017.5724
_version_ 1783231382278897664
author Liu, Min
Li, Ruizhe
Tang, Yang
Chang, Jiwu
Han, Rong
Zhang, Shumin
Jiang, Ning
Ma, Fuling
author_facet Liu, Min
Li, Ruizhe
Tang, Yang
Chang, Jiwu
Han, Rong
Zhang, Shumin
Jiang, Ning
Ma, Fuling
author_sort Liu, Min
collection PubMed
description The aim of the present study was to explore use of the acridine orange fluorescence (AO-F) staining method for screening of circulating tumor cells (CTCs) in renal cell carcinoma (RCC) patients. The AO-F positive staining rate of live and dead tumor cells was calculated. The positive staining rate in the live group was 93.4±3.0%, while the dead group failed to emit specific fluorescence. A known number of tumor cells were added to peripheral blood, and the detection sensitivity of the four groups (50, 100, 200 and 500 cells/tube) was 10.2±3.8, 9.2±2.3, 10.8±2.6 and 10.5±1.9%, respectively. The average detection sensitivity of the four groups was 10.16±2.73%. There was a positive correlation between the number of cells that was positively stained with AO-F and the total number cells in the system (χ(2)=0.959; P<0.001). Subsequently, the AO-F staining method was used to detect positive staining cells in 8 healthy volunteers (control group), and 112 non-metastatic and 27 metastatic RCC patients. The positive staining rate was 13.67% (19/139) in RCC patients, while none of the control group was positive. The AO-F positive staining rate was not significantly different between the metastatic and non-metastatic patients according to age, gender, the pathological pattern, T2/3 (according to the Tumor-Node-Metastasis classification) or Fuhrman grade, while there was a significant difference according to T1. The positive staining rate was 8.93% (10/112) for non-metastatic patients and 33.33% (9/27) for metastatic patients, which showed a significant difference (P<0.05). In 112 non-metastatic and 27 metastatic patients, the positive staining rate was not significantly associated with gender, age, tumor size, the pathological pattern, T classification, Fuhrman grade, the presence of a lesion or metastasis to the lungs. The present study demonstrated that the method of CTC staining with AO-F, which has high reproducibility and specificity, was feasible for identifying CTCs and warrants further study.
format Online
Article
Text
id pubmed-5403171
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-54031712017-04-27 New applications of the acridine orange fluorescence staining method: Screening for circulating tumor cells Liu, Min Li, Ruizhe Tang, Yang Chang, Jiwu Han, Rong Zhang, Shumin Jiang, Ning Ma, Fuling Oncol Lett Articles The aim of the present study was to explore use of the acridine orange fluorescence (AO-F) staining method for screening of circulating tumor cells (CTCs) in renal cell carcinoma (RCC) patients. The AO-F positive staining rate of live and dead tumor cells was calculated. The positive staining rate in the live group was 93.4±3.0%, while the dead group failed to emit specific fluorescence. A known number of tumor cells were added to peripheral blood, and the detection sensitivity of the four groups (50, 100, 200 and 500 cells/tube) was 10.2±3.8, 9.2±2.3, 10.8±2.6 and 10.5±1.9%, respectively. The average detection sensitivity of the four groups was 10.16±2.73%. There was a positive correlation between the number of cells that was positively stained with AO-F and the total number cells in the system (χ(2)=0.959; P<0.001). Subsequently, the AO-F staining method was used to detect positive staining cells in 8 healthy volunteers (control group), and 112 non-metastatic and 27 metastatic RCC patients. The positive staining rate was 13.67% (19/139) in RCC patients, while none of the control group was positive. The AO-F positive staining rate was not significantly different between the metastatic and non-metastatic patients according to age, gender, the pathological pattern, T2/3 (according to the Tumor-Node-Metastasis classification) or Fuhrman grade, while there was a significant difference according to T1. The positive staining rate was 8.93% (10/112) for non-metastatic patients and 33.33% (9/27) for metastatic patients, which showed a significant difference (P<0.05). In 112 non-metastatic and 27 metastatic patients, the positive staining rate was not significantly associated with gender, age, tumor size, the pathological pattern, T classification, Fuhrman grade, the presence of a lesion or metastasis to the lungs. The present study demonstrated that the method of CTC staining with AO-F, which has high reproducibility and specificity, was feasible for identifying CTCs and warrants further study. D.A. Spandidos 2017-04 2017-02-13 /pmc/articles/PMC5403171/ /pubmed/28454384 http://dx.doi.org/10.3892/ol.2017.5724 Text en Copyright: © Liu et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Liu, Min
Li, Ruizhe
Tang, Yang
Chang, Jiwu
Han, Rong
Zhang, Shumin
Jiang, Ning
Ma, Fuling
New applications of the acridine orange fluorescence staining method: Screening for circulating tumor cells
title New applications of the acridine orange fluorescence staining method: Screening for circulating tumor cells
title_full New applications of the acridine orange fluorescence staining method: Screening for circulating tumor cells
title_fullStr New applications of the acridine orange fluorescence staining method: Screening for circulating tumor cells
title_full_unstemmed New applications of the acridine orange fluorescence staining method: Screening for circulating tumor cells
title_short New applications of the acridine orange fluorescence staining method: Screening for circulating tumor cells
title_sort new applications of the acridine orange fluorescence staining method: screening for circulating tumor cells
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5403171/
https://www.ncbi.nlm.nih.gov/pubmed/28454384
http://dx.doi.org/10.3892/ol.2017.5724
work_keys_str_mv AT liumin newapplicationsoftheacridineorangefluorescencestainingmethodscreeningforcirculatingtumorcells
AT liruizhe newapplicationsoftheacridineorangefluorescencestainingmethodscreeningforcirculatingtumorcells
AT tangyang newapplicationsoftheacridineorangefluorescencestainingmethodscreeningforcirculatingtumorcells
AT changjiwu newapplicationsoftheacridineorangefluorescencestainingmethodscreeningforcirculatingtumorcells
AT hanrong newapplicationsoftheacridineorangefluorescencestainingmethodscreeningforcirculatingtumorcells
AT zhangshumin newapplicationsoftheacridineorangefluorescencestainingmethodscreeningforcirculatingtumorcells
AT jiangning newapplicationsoftheacridineorangefluorescencestainingmethodscreeningforcirculatingtumorcells
AT mafuling newapplicationsoftheacridineorangefluorescencestainingmethodscreeningforcirculatingtumorcells